肠道菌群对代谢综合征相关性脑卒中影响的研究进展
Research Progress on the Influence of Gut Microbiota on Metabolic Syndrome-Associated Stroke
DOI: 10.12677/ACM.2021.118507, PDF,   
作者: 杨常慧, 宫健伟：莱山区滨州医学院康复医学院，山东 烟台；晁 倩：峄城区中医院康复科，山东 枣庄
关键词: 肠道菌群；脑卒中；代谢综合征；粪菌移植；Gut Microbiota； Stroke； Metabolic Syndrome； Fecal Microbiota Transplants
摘要: 代谢综合征(Metabolic syndrome, MS)作为脑卒中的关键高危因素可显著增加脑卒中的患病率及死亡率。众多研究表明，肠道菌群和脑卒中及代谢综合征之间存在着密切的联系。本文将脑卒中和代谢综合征视为一个复合的整体，综述代谢综合征相关性脑卒中患者的肠道菌群对其疾病的影响以及相关性研究进展。
Abstract: Metabolic syndrome, as a key factor of stroke, can significantly increase the prevalence and mortality of stroke. Numerous studies have shown a close link between intestinal bacteria and stroke and metabolic syndrome. In this paper, stroke and metabolic syndrome are regarded as a composite whole, and the effect of intestinal bacteria on the disease and the related research progress of stroke patients with metabolic syndrome are reviewed.
文章引用：杨常慧, 晁倩, 宫健伟. 肠道菌群对代谢综合征相关性脑卒中影响的研究进展[J]. 临床医学进展, 2021, 11(8): 3481-3486. https://doi.org/10.12677/ACM.2021.118507

参考文献

[1] 王亚楠, 吴思缈, 刘鸣. 中国脑卒中15年变化趋势和特点[J]. 华西医学, 2021, 36(6): 803-807.
[2] 《中国脑卒中防治报告》编写组. 《中国脑卒中防治报告2019》概要[J]. 中国脑血管病杂志, 2020, 17(5): 272-281.
[3] 张培培, 张祥建, 高硕君. 肠道菌群失调可增加脑卒中风险[J]. 中华神经科杂志, 2017, 50(10): 781-785.
[4] 刘伟, 方黎, 江选东, 李中秋. 老年急性脑梗死合并代谢综合征患者的认知损伤表现分析[J]. 中国实用神经疾病杂志, 2014, 17(22): 26-27, 28.
[5] 石强. 脑梗死合并代谢综合征的临床特征及预后分析[J]. 实用临床医药杂志, 2015, 19(15): 14-17.
[6] Mazidi, M., Rezaie, P., Kengne, A.P., Mobarhan, M.G. and Ferns, G.A. (2016) Gut Microbiome and Metabolic Syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 10, S150-S157. [Google Scholar] [CrossRef] [PubMed]
[7] Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V.D., Sokol, H, Doré, J., et al. (2009) The Firmicutes/Bacteroidetes Ratio of the Human Microbiota Changes with Age. BMC Microbiology, 9, Article No. 123. [Google Scholar] [CrossRef] [PubMed]
[8] Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva Datchary, P., et al. (2015) Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host & Microbe, 17, 690-703. [Google Scholar] [CrossRef] [PubMed]
[9] Winek, K., Meisel, A. and Dirnagl, U. (2016) Gut Microbiota Impact on Stroke Outcome: Fad or Fact? Journal of Cerebral Blood Flow & Metabolism, 36, 891-898. [Google Scholar] [CrossRef] 
[10] Tan, B.Y.Q., Paliwal, P.R. and Sharma, V.K. (2020) Gut Microbiota and Stroke. Annals of Indian Academy of Neurology, 23, 155-158.
[11] Kazlauskienė, L., Butnorienė, J. and Norkus, A. (2015) Metabolic Syndrome Related to Cardiovascular Events in a 10-Year Prospective Study. Diabetology & Metabolic Syndrome, 7, Article No. 102. [Google Scholar] [CrossRef] [PubMed]
[12] Fang, X., Liu, H., Zhang, X., Zhang, H., Qin, X. and Ji, X. (2016) Metabolic Syndrome, Its Components, and Diabetes on 5-Year Risk of Recurrent Stroke among Mild-to-Moderate Ischemic Stroke Survivors: A Multiclinic Registry Study. Journal of Stroke and Cerebrovascular Diseases, 25, 626-634. [Google Scholar] [CrossRef] [PubMed]
[13] Zuo, H.J., Xie, Z.M., Zhang, W.W., Li, Y.-R., Wang, W., Ding, X.-B., et al. (2011) Gut Bacteria Alteration in Obese People and Its Relationship with Gene Polymorphism. World Journal of Gastroenterology, 17, 1076-1081.
[14] Tseng, C.H. and Wu, C.Y. (2019) The Gut Microbiome in Obesity. Journal of the Formosan Medical Association, 118, S3-S9. [Google Scholar] [CrossRef] [PubMed]
[15] Lee, C.J., Sears, C.L. and Maruthur, N. (2020) Gut Microbiome and Its Role in Obesity and Insulin Resistance. Annals of the New York Academy of Sciences, 1461, 37-52. [Google Scholar] [CrossRef] [PubMed]
[16] Li, X., Liu, L., Cao, Z., Li, W., Li, H., Lu, C., et al. (2020) Gut Microbiota as an “Invisible Organ” That Modulates the Function of Drugs. Biomedicine & Pharmacotherapy, 121, Article ID: 109653. [Google Scholar] [CrossRef] [PubMed]
[17] Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance. Diabetes, 56, 1761-1772. [Google Scholar] [CrossRef] [PubMed]
[18] Li, J., Zhang, H. and Wang, G. (2020) Correlations between Inflammatory Response, Oxidative Stress, Intestinal Pathological Damage and Intestinal Flora Variation in Rats with Type 2 Diabetes Mellitus. European Review for Medical and Pharmacological Sciences, 24, 10163-10168.
[19] Silva, Y.P., Bernardi, A. and Frozza, R.L. (2020) The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Frontiers in Endocrinology, 11, Article No. 25. [Google Scholar] [CrossRef] [PubMed]
[20] Zhu, W., Gregory, J.C., Org, E., Buffa, J.A., Gupta, N., Wang, Z., et al. (2016) Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell, 165, 111-124. [Google Scholar] [CrossRef] [PubMed]
[21] Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., et al. (2012) A Metagenome-Wide Association Study of gut Microbiota in Type 2 Diabetes. Nature, 490, 55-60. [Google Scholar] [CrossRef] [PubMed]
[22] 陈诚, 陆明, 夏娟, 陈琳, 雷涛. 肠道菌群与2型糖尿病关系的研究进展[J]. 医学综述, 2017, 23(15): 3072-3076.
[23] Canfora, E.E., Meex, R.C.R., Venema, K. and Blaak, E.E. (2019) Gut Microbial Metabolites in Obesity, NAFLD and T2DM. Nature Reviews. Endocrinology, 15, 261-273. [Google Scholar] [CrossRef] [PubMed]
[24] Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C.J., Fagerberg, B., et al. (2013) Gut Metagenome in European Women with Normal, Impaired and Diabetic Glucose Control. Nature, 498, 99-103. [Google Scholar] [CrossRef] [PubMed]
[25] Ma, Q., Li, Y., Li, P., Wang, M., Tang, Z., Wang, T., et al. (2019) Research Progress in the Relationship between Type 2 Diabetes Mellitus and Intestinal Flora. Biomedicine & Pharmacotherapy, 117, Article ID: 109138. [Google Scholar] [CrossRef] [PubMed]
[26] Honour, J. (1982) The Possible Involvement of Intestinal Bacteria in Steroidal Hypertension. Endocrinology, 110, 285-287. [Google Scholar] [CrossRef] [PubMed]
[27] Yang, T., Santisteban, M.M., Rodriguez, V., Li, E., Ahmari, N., Carvajal, J.M., et al. (2015) Gut Dysbiosis Is Linked to Hypertension. Hypertension, 65, 1331-1340. [Google Scholar] [CrossRef] 
[28] Li, J., Zhao, F., Wang, Y., Chen, J., Tao, J., Tian, G., et al. (2017) Gut Microbiota Dysbiosis Contributes to the Development of Hypertension. Microbiome, 5, Article No. 14. [Google Scholar] [CrossRef] [PubMed]
[29] Jose, P.A. and Raj, D. (2015) Gut Microbiota in Hypertension. Current Opinion in Nephrology and Hypertension, 24, 403-409. [Google Scholar] [CrossRef] 
[30] Li, J., Yang, X., Zhou, X. and Cai, J. (2021) The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development. Antioxidants & Redox Signaling, 34, 811-830. [Google Scholar] [CrossRef] [PubMed]
[31] Wilck, N., Matus, M.G., Kearney, S.M., Olesen, S.W., Forslund, K., Bartolomaeus, H., et al. (2017) Salt-Responsive Gut Commensal Modulates TH17 Axis and Disease. Nature, 551, 585-589. [Google Scholar] [CrossRef] [PubMed]
[32] Wang, J., Kuo, C.-H., Kuo, F.-C., Wang, Y.-K., Hsu, W.-H., Yu, F.-J., et al. (2019) Fecal Microbiota Transplantation: Review and Update. Journal of the Formosan Medical Association, 118, S23-S31. [Google Scholar] [CrossRef] [PubMed]
[33] Adak, A. and Khan, M.R. (2019) An Insight into Gut Microbiota and Its Functionalities. Cellular and Molecular Life Sciences, 76, 473-493. [Google Scholar] [CrossRef] [PubMed]
[34] Smits, L.P., Kootte, R.S., Levin, E., Prodan, A., Fuentes, S., Zoetendal, E.G., et al. (2018) Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients with Metabolic Syndrome. Journal of the American Heart Association, 7, Article No. e008342. [Google Scholar] [CrossRef] 
[35] Torres-Fuentes, C., Schellekens, H., Dinan, T.G. and Cryan, J.F. (2017) The Microbiota-Gut-Brain Axis in Obesity. Lancet Gastroenterology & Hepatology, 2, 747-756. [Google Scholar] [CrossRef] 

为你推荐